• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900F
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Abdominal Pain (1685)
Event Date 05/09/2018
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history record review could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Bard denali retrievable filter was deployed with the tip of the catheter at the l1-l2 disc space in a patient with deep vein thrombosis.The filter deployed well with no tilt identified.Approximately one year and nine months of post deployment, computerized tomography-abdomen was performed which showed that appropriate inferior vena cava filter position with minimal transmural protrusion of filter struts anteriorly and to the left.The long axis of the filter was within 5 degrees of the inferior vena cava long axis.The tip of the filter does not contact the inferior vena cava walls.A metallic inferior vena cava filter with 12 struts was oriented longitudinally in the inferior vena cava.The tip of the filter was located 1.5 cm below the renal veins.There was no visible fracture or deformity of the metallic struts.In the axial plane, a strut at the 12:00 position protrudes 2 mm through the anterior inferior vena cava wall, contacting but not penetrating the posterior wall of the transverse duodenum.Struts at the 2:00 and 3:00 positions protrude 3 mm.The inferior vena cava wall, contacting but not penetrating abdominal aorta.There is no retroperitoneal hematoma or fibrosis, and no evidence of filter migration.One year and nine months earlier, the patient presented with lower abdominal pain.Also noted to had protrusion of the filter struts however remains in appropriate position.Therefore, the investigation is confirmed for perforation of inferior vena cava (ivc).Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter strut perforated the inferior vena cava wall and contacting the abdominal aorta.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI FEMORAL SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12075339
MDR Text Key258634586
Report Number2020394-2021-80531
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040801
UDI-Public(01)00801741040801
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/28/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDL900F
Device Catalogue NumberDL900F
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received06/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN, MIRTAZAPINE, BUMETANIDE, LEVOTHYROXINE; BUSPIRONE, MONTELUKAST, OMEPRAZOLE; CHROMIUM PICOLINATE, LOVENOX, ZOFRAN; COQ10, FISH OIL, LISINOPRIL, REMERON; HYDROCODONE, DULCOLAX, MIRALAX; LORTAB, SERTRALINE, POTASSIUM CHLORIDE, PREMARIN; PRAVASTATIN, TOPAMAX; SINGULAIR, ZOLOFT, VITAMIN B12, MELOXICAM; THEOPHYLLINE, TOPIRAMATE, CLONAZEPAM; XARELTO, ZYRTEC, MELATONIN, MULTIVITAMIN
Patient Outcome(s) Other;
Patient Age70 YR
Patient Weight91
-
-